Economic Performance: Investors

Information on distributions, dividends, debt and borrowings, and retained earnings can be found on the Investor Relations page of the Bristol-Myers Squibb website, including our Annual Report and the latest Form 10K report filed with the U.S. Securities and Exchange Commission.

Socially Responsible Investment

Several premier socially responsible investment funds feature Bristol-Myers Squibb in their portfolios.

In September 2006, Bristol-Myers Squibb was included in the Dow Jones Sustainability North America Index of leading sustainability-driven companies in North America. The Dow Jones Sustainability North America Index selects companies based on a systematic corporate sustainability assessment that identifies the leading sustainability-driven companies in each industry group.
In the October 2006 Global Pharmaceutical Sector Report released by Innovest Strategic Value Advisors, Bristol-Myers Squibb ranked 6 out of 44 firms with a "AA" rating.
The German corporate social responsibility rating agency oekom research AG released in April 2005 its ranking of the world's 27 largest pharmaceutical and biotechnology companies. Bristol-Myers Squibb ranked among the top five for social and environmental performance. The evaluations by oekom research are used by managers responsible for funds with a total value of over one billion euros.
Bristol-Myers Squibb is ranked 22 out of the world's top 50 corporate environmental and sustainability reporters, according to a joint report by SustainAbility, the United Nations Environmental Programme, and Standard and Poor's. Published in 2004, the report Risk and Opportunities: Best Practices in Non-Financial Reporting, ranks Bristol-Myers Squibb among the top two pharmaceutical companies and top three U.S.-based companies. Bristol-Myers Squibb is one of a select few companies to make the top 50 list in all three benchmark surveys of corporate non-financial reporting by SustainAbility and UNEP.
Storebrand Investments, a leading Scandinavian financial services company with over 20 billion euros under management, has ranked Bristol-Myers Squibb as "best in class" based on the company's environmental and social performance.
As of July 2004, Bristol-Myers Squibb held one of the top five largest positions of the UBS (Lux) Equity Fund - Eco Performance B. The fund invests worldwide in companies that generate above average environmental, social, and economic performance, and offer interesting growth potential.
Bristol-Myers Squibb is part of the Calvert Social Index of companies. The Calvert Group, a leader in socially responsible investing, has created the Social Index, a broad-based, rigorously constructed benchmark for measuring the performance of U.S.-based socially responsible companies.

Last updated November 3, 2006 . Italicized product names are registered trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Copyright © 1998-2006 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notices.